Open AccessImpacts of Generic Competition and Benefit Management Practices on Spending for Prescription Drugs: Evidence from Medicare’s Part D Benefit
Author(s) -
Steven H. Sheingold,
Nguyen Xuan Nguyen
Publication year - 2014
Publication title -
medicare and medicaid research review
Language(s) - English
Resource type - Journals
ISSN - 2159-0354
DOI - 10.5600/mmrr.004.01.a01
Subject(s) - copayment , medical prescription , competition (biology) , competitor analysis , medicare part d , prescription drug , business , cost sharing , generic drug , actuarial science , drug , medicine , marketing , economics , health care , pharmacology , health insurance , ecology , biology , economic growth , nursing
This study estimates the effects of generic competition, increased cost-sharing, and benefit practices on utilization and spending for prescription drugs.